ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Health Technology

euglena Co., Ltd.

Business Summary

euglena Co., Ltd. engages in the research, development, production and sale of microalgae products. It operates through the Healthcare; and Energy and Environment segments. The Healthcare segment handles the planning and sale of in-house products, food products and cosmetics using algae.The Energy and Environment segment deals with funded research and technology development with a focus on microalgae. It also engages in the development of bio fuel production technology and investment in bio-tech related business. The company was founded by Mitsuru Izumo, Kengo Suzuki and Takuyuki Fukumoto on August 9, 2005 and is headquartered in Tokyo, Japan.

Financial Highlights

Dec 2021 JPYUSD
Gross Profit16,217.95M147.60M
Operating income-5,252.18M-47.80M
Income before tax-5,389.96M-49.05M
Net income-4,031.15M-36.68M
Diluted EPS-39.25-0.35
Dividends Per Share00
Total Assets61,007.73M529.78M
Total liabilities40,418.87M350.99M
Total equity20,583.31M178.74M
Operating cash flow1,378.49M12.54M
Currency in JPYCurrency in USD

Historical Data

 Sep 2017Sep 2018Sep 2019Sep 2020Dec 2021
Revenue 13,886.60M 15,174.58M 13,967.67M 13,317.31M 27,536.30M
Gross Profit 10,082.03M 10,755.49M 9,731.69M 9,199.98M 16,217.95M
Operating income 950.93M -1,379.62M -7,460.14M -1,807.72M -5,252.18M
Income before tax 1,205.53M -1,109.22M -9,604.98M -1,434.22M -5,389.96M
Net income 785.88M -1,252.19M -9,798.56M -1,486.68M -4,031.15M
EBITDA 1,413.03M -613.67M -6,503.60M -1,088.90M -3,498.66M
Diluted EPS 9.38 -14.70 -107.24 -16.00 -39.25
Dividends Per Share 0 0 0 0 0
Total Assets 18,858.06M 21,837.61M 17,199.44M 15,351.09M 61,007.73M
Total liabilities 3,202.78M 5,932.78M 6,365.06M 5,964.33M 40,418.87M
Total equity 15,643.36M 15,900.39M 10,826.65M 9,376.98M 20,583.31M
Operating cash flow 153.75M -1,238.02M 1,089.39M -1,217.47M 1,378.49M
 Sep 2017Sep 2018Sep 2019Sep 2020Dec 2021
Revenue 124.77M 137.37M 126.93M 123.50M 250.61M
Gross Profit 90.59M 97.36M 88.44M 85.32M 147.60M
Operating income 8.54M -12.48M -67.79M -16.76M -47.80M
Income before tax 10.83M -10.04M -87.29M -13.30M -49.05M
Net income 7.06M -11.33M -89.04M -13.78M -36.68M
EBITDA 12.69M -5.55M -59.10M -10.09M -31.84M
Diluted EPS 0.08 -0.13 -0.97 -0.14 -0.35
Dividends Per Share 0 0 0 0 0
Total Assets 167.53M 192.25M 159.14M 145.46M 529.78M
Total liabilities 28.45M 52.23M 58.89M 56.51M 350.99M
Total equity 138.97M 139.98M 100.17M 88.85M 178.74M
Operating cash flow 1.38M -11.20M 9.90M -11.29M 12.54M

Valuation Measures

Dec 2021
Operating margin-19.07%
Profit margin-14.63%

Key executives

  • President & Representative Director: Mitsuru Izumo
  • Executive Officer, Head-Research & Development: Kengo Suzuki
  • Manager-Information System: Shuji Endo
  • Director, VP & Manager-Corporate Strategy: Akihiko Nagata
  • Executive Officer & Head-Healthcare Sales: Takuyuki Fukumoto


  • IZUMO MITSURU (11.0%)
  • Nomura Asset Management Co., Ltd. (3.0%)
  • The Vanguard Group, Inc. (1.9%)
  • Nikko Asset Management Co., Ltd. (1.5%)
  • Daiwa Asset Management Co. Ltd. (1.3%)
  • BlackRock Fund Advisors (1.3%)
  • Tokyo Century Corp. (0.8%)
  • Triodos Investment Management BV (Investment Management) (0.8%)
  • Davy Global Fund Management Ltd. (0.8%)
  • SUZUKI KENGO (0.7%)

Contact Details

  • Website:
  • Address: G-BASE Tamachi 2-3/F, 5-29-11 Shiba, Tokyo, 108-0014, Japan
  • Phone: +81.3.3453.4907

Related Companies

  • Frembassy, Inc.
  • MEJ Inc.
  • Sports Innovation KK
  • Euglena Restricted Stock Compensation Plan
  • Euglena Investment Co. Ltd.
  • HELLSEN, Inc.
  • HOOK Inc.
  • euglena Taketomi Ebi Yoshoku KK
  • Euglena Art KK
  • Genequest, Inc.
  • Plant High Technology Institute KK
  • Yaeyama Shokusan Co., Ltd.
  • epauler Co., Ltd.
  • Art Corp. KK
  • Daikyo Hiryo KK
  • Chlorella Supply Co., Ltd.


    Last Updated on 27 Jun, 2022

    Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

    Celebrate our next chapter
    Free access for everyone - Sep. 30

    Find out more